Neil E. Stahl - 21 Aug 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/**Neil Stahl
Issuer symbol
REGN
Transactions as of
21 Aug 2023
Net transactions value
-$21,775,088
Form type
4
Filing time
23 Aug 2023, 16:03:35 UTC
Previous filing
20 Dec 2022
Next filing
14 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $19,983,000 +50,000 +94% $399.66 103,100 21 Aug 2023 Direct
transaction REGN Common Stock Tax liability $31,948,006 -38,335 -37% $833.39 64,765 21 Aug 2023 Direct
transaction REGN Common Stock Sale $5,302,904 -6,309 -9.7% $840.53 58,456 22 Aug 2023 Direct F1
transaction REGN Common Stock Sale $3,848,609 -4,574 -7.8% $841.41 53,882 22 Aug 2023 Direct F2
transaction REGN Common Stock Sale $658,569 -782 -1.5% $842.16 53,100 22 Aug 2023 Direct F3
holding REGN Common Stock 5,834 21 Aug 2023 By 401(k) Plan
holding REGN Common Stock 4,605 21 Aug 2023 by Spouse as Trustee

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -50,000 -62% $0.000000 30,750 21 Aug 2023 Common Stock 50,000 $399.66 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 6,309 shares of Company stock on August 22, 2023 at prices ranging from $840.00 to $840.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 22, 2023 at each separate price.
F2 Represents volume-weighted average price of sales of 4,574 shares of Company stock on August 22, 2023 at prices ranging from $841.01 to $841.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 22, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 782 shares of Company stock on August 22, 2023 at prices ranging from $842.01 to $842.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 22, 2023 at each separate price.
F4 The stock option award vests in four equal annual installments, commencing one year after the date of grant.